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Cancer is a disease that needs a multi-faceted approach from different systems of med-
icine. The purpose of this study was to evaluate whether homeopathically-potentized ul-
tra-high dilutions of Lycopodium Clavatum (LC-5C and LC-15C, respectively) have any
anti-cancer effects on HeLa cells. Cells were exposed to either LC-5C (diluted below
Avogadro’s limit, i.e., 1010) or LC-15C (diluted beyond Avogadro’s limit, i.e., 1030)
(drug-treated) or to 30% succussed ethanol (“vehicle” of the drug). The drug-induced
modulation in the percent cell viability, the onset of apoptosis, and changes in the ex-
pressions of Bax, Bcl2, caspase 3, and Apaf proteins in inter-nucleosomal DNA, in mito-
chondrial membrane potentials and in the release of cytochrome-c were analyzed by
utilizing different experimental protocols. Results revealed that administration of LC-
5C and LC-15C had little or no cytotoxic effect in normal peripheral blood mononuclear
cells, but caused considerable cell death through apoptosis in cancer (HeLa) cells, which
was evident from the induction of DNA fragmentation, the increases in the expressions of
protein and mRNA of caspase 3 and Bax, and the decreases in the expressions of Bcl2 and
Apaf and in the release of cytochrome-c. Thus, the highly-diluted, dynamized homeo-
pathic remedies LC-5C and LC-15C demonstrated their capabilities to induce apoptosis




Potentized Lycopodium Shows Anti-cancer Potential 1811. Introduction were purchased from Sigma-Aldrich Inc. (St-Louis, MO,Cervical cancer is the third most common type of cancer in
women worldwide. It carries few or no obvious symptoms
until it has progressed to an advanced stage. Therefore, the
treatment usually consists of chemotherapy and/or radio-
therapy [1]. These orthodox modes of treatment are often
painful and are associated with considerable side effects.
Further, people often look for other modes of treatment
that have relatively fewer or no side effects and can com-
plement the orthodox treatment.
Homeopathy is one such arm of complementary and
alternative therapy that causes the patient no pain and has
no or negligible side effects with use [2]. Homeopathic
medicines are available at affordable prices and are
therefore becoming increasingly popular in many devel-
oping countries. In spite of the growing popularity of ho-
meopathy, concerns still remain in respect of its
experimental validation and mechanism of action. In
particular, questions are often raised about the rationale
behind using ultrahigh dilutions of the remedies (exceeding
Avogadro’s limit), which are not expected to contain even a
single molecule of the original drug substance as a result of
the repeated dilutions [3]. Therefore, validation through
well-designed experiments is greatly warranted to convince
both skeptics and believers.
To understand the concept of “potentization” in the
centesimal scale (C), the homeopathic procedure of dilu-
tion needs to be explained. First, 1 mL of the “mother
tincture”, the crude ethanolic extract of Lycopodium
clavatum, is diluted with 30e90% ethanol (mostly 90% and
70%, but in some cases 30% is also used) and given 10 uni-
form jerks to make the potency 1C. A volume of 1 mL of
potency 1C is then diluted with 99 mL of ethanol and given
10 jerks or succussions to make the potency 2C, and so on
[4,5]. Thus, there may be a physical presence of some
original drug molecules at potency 5C, but it is highly
improbable that potency 15C will contain even a single
original molecule of the drug because the dilution has gone
beyond Avogadro’s limit.
Homeopathic practitioners use mother tinctures, as
well as potentized remedies diluted to both below and
above Avogadro’s limit, depending on the patient’s con-
dition, and claim to find all remedies effective against the
disease symptoms for a given condition. Therefore, in this
study, we chose two potencies, 5C (below Avogadro’s
limit) and 15C (above Avogadro’s limit), to test primarily
whether the diluted potencies could still show efficacy in
leading the otherwise immortal cancer cells HeLa to
apoptosis (cell death) in culture conditions. Incidentally,
many earlier reports have recorded efficacy of both the
lower and the higher potencies of homeopathic remedies
[6e9].2. Materials and methods
2.1. Reagents
MTT [3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium
bromide], secondary antibodies, and all other chemicalsUSA). The primary antibodies (Bcl2 associated X (Bax), B
cell lymphoma 2 (Bcl2), caspase 3, Apoptotic protease
activating factor 1 (Apaf1), and cytochrome C) were pro-
cured from Santa Cruz, California, U.S.A. Dulbecco’s
modified Eagle’s medium (DMEM), fetal bovine serum, and
penicillin, streptomycin, and neomycin (PSN) antibiotics
were purchased from Gibco BRL (Grand Island, NY, USA). All
organic solvents used were of high-performance liquid
chromatography grade.
2.2. Cell culture
The human cervical cancer cell line HeLa was procured
from National Centre for Cell Science (NCCS, Pune, India).
The cells were cultured at 5  105 cells/mL in DMEM sup-
plemented with 10% fetal bovine serum and 1% PSN anti-
biotic at 37C in 5% CO2 for experimental purposes.
2.3. Assessment of viable cells
The viability of the HeLa cells was evaluated by the MTT
assay [10] after exposure to LC-5C and LC-15C. The cells
were incubated in 96-well microplates for 24 hours with and
without the drugs. The intracellular formazan crystals
formed were solubilized with dimethyl sulfoxide, and the
absorbance of the solution was measured at 595 nm using a
microplate reader (Multiskan ELISA; Thermo Scientific,
Brookfield, WI, United States). The cell survival percentage
on MTT assay was calculated using the following equation:
percentage of survivalZ (mean experimental absorbance /
mean control absorbance)  100.
2.4. Use of negative control, placebo control, and
selection of dose of the drugs
Untreated HeLa cells were used as a negative control, while
the vehicle-treated (placebo) treated samples were used as
a positive control. Additionally, a widely used chemother-
apeutic drug, cisplatin [11], from the orthodox regimen,
was also used to make a basic comparison of the cancer
cell-killing efficiency of the two tested drugs from two
different systems, by determining the percentage surviv-
ability using the MTT assay. Because the results of the pri-
mary MTT assay revealed that cisplatin and both potencies
of the homeopathic drug (LC-5C and LC-15C) showed an
almost similar apoptotic effect on the HeLa cervical cancer
cells, we did not deem it necessary to proceed further with
other parameters of the study using this control as our
primary objective was to evaluate only the anticancer po-
tential of the potentized homeopathic drug.
Two different doses of LC-5C and LC-15C were selected
for further experiments based on their respective LD50
values. The doses that were selected for LC-5C and LC-
15C were: 5 mL/100 mL media [LC-5C(I)], 6 mL/100 mL
media [LC-5C(II)], 7 mL/100 mL media [LC-15C(I)], and 8
mL/100 mL media [LC-15C(II)], respectively. Normal pe-
ripheral blood mononuclear cells (PBMCs) were also
cultured and exposed to LC-5C and LC-15C, in a concen-
tration determined from MTT assay, to test their cytotoxic
effect, if any [12].
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The cellular membrane integrity of HeLa cells was checked
at 24 hours of incubation with LC-5C and LC-15C using the
activity of lactate dehydrogenase (LDH) released from the
cytosol of damaged cells into the supernatant; this was
measured using an LDH determination kit (LDH1144; Crest
Biosystems, Goa, India). The floating cells were collected
from the culture medium by centrifugation (1000 g) at 4C
for 5 minutes, and the LDH content of the pellets (LDHp)
was used as an index of apoptotic cell death [11]. The LDH
released to the culture supernatant, designated as extra-
cellular LDH (LDHe), was used as an index of necrotic
death, and the LDH present in the adherent viable cells was
designated as intracellular LDH (LDHi). The percentages of
apoptotic and necrotic cell death were calculated as
follows:
Apoptotic percentageZ½LDHp=ðLDHpþ LDHiþ LDHeÞ  100
Necrotic percentageZ½LDHe=ðLDHpþ LDHiþ LDHeÞ  100
2.6. Fluorescence study by Hoechst 33342 and
propidium iodide staining
The extent of apoptosis in the HeLa cells was assessed by
Hoechst 33342 and propidium iodide (PI) staining (1 mg/
mL), and the fluorescence intensity was examined using a
fluorescence microscope (Leica, Wetzlar, Germany)
[10,13].
2.7. Assessment of mitochondrial membrane
potential by rhodamine 123
The changes in the mitochondrial membrane potential
(MMP) of the cells were determined using a fluorescent
probe, rhodamine 123 [14]. Briefly, the HeLa cells were
incubated using the two selected doses, LC-5C and LC-
15C, for 24 hours. The cells were then washed in
phosphate-buffered saline (PBS), and 5 mL of rhodamine
123 (1mM) was added to the cells (2  105). The cells were
then incubated for 15 minutes. Next, the cells were
washed with PBS and observed under a fluorescence mi-
croscope (Leica).
2.8. Double labeling of cells with Annexin
Vefluorescein isothiocyanate and PI
Measures of 1  106 cells per sample were placed into
small centrifuge tubes. The cells were spun at 1200 g for 5
minutes, the supernatant was discarded, and the pellets
were washed with 500 mL binding buffer. Then cells were
harvested at 1200 g for 5 minutes, and the cell pellets
were resuspended in 80 mL binding buffer. Annexin
Vefluorescein isothiocyanate (FITC) 10 mL and 10 mL of PI
labeling solution were added, and the cell suspension was
incubated for 15 minutes at room temperature in the
dark. The solution was then ready for analysis by flow
cytometry [15].2.9. Estimation of DNA damage
The genomic DNA was extracted from HeLa cells by a
standardized phenolechloroform method, and DNA gel
electrophoresis was performed in 1% agarose gel [16].
2.10. Expression of proteins by indirect enzyme-
linked immunosorbent assay study
Enzyme-linked immunosorbent assay (ELISA) studies were
carried out using a nuclear extract of the cells to quantify the
expression of Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), Bax, Bcl2, Apaf, cytochrome C, and caspase 3
proteins according to a standard protocol [14].
2.11. Statistical analysis
Data were presented as means  standard error (SE). Sta-
tistical analysis was performed using the Student paired t
test analysis and one-way analysis of variance (ANOVA); *
p < 0.001, y p < 0.01, z p < 0.05 were considered
significant.
3. Results
3.1. Proliferative assay: by MTT
The proliferation of HeLa cells decreased with an increase
in concentration of LC-5C and LC-15C. The percentage of
cell viability is shown in Fig. 1A. From the curve of the HeLa
cells (5  105 cells/mL), it can be clearly observed that 5
mL/100 mL media of LC-5C and 7 mL/100 mL media of LC-15C
decreased cell viability to 50.94% and 50.98%, respectively,
at 24 hours. This trend of a decrease in the percentage cell
viability of the HeLa cells was found to be similar to that of
the chemotherapeutic drug cisplatin (50.3% at 24 hours of
incubation and at a 20mM dose; Fig. 1B). This suggests that
both our drugs of interest, LC-5C and LC-15C, could be
further evaluated for their anticancer potency. The per-
centage cell cytotoxicity of the drugs was also checked on
normal PBMCs, resulting in minimal cytotoxic effect
(Fig. 1C).
3.2. Assessment of apoptotic and necrotic cells by
LDH assay
The ratio of LDH released from apoptotic and necrotic cells
showed a significant increase in the ratio of apoptotic cells
compared to necrotic cells (Fig. 1D). The ratio increased in
a dose-dependent manner.
3.3. PI and Hoechst 33258 staining
HeLa cells treated with LC-5C and LC-15C stained positively
with PI (Fig. 2A) and Hoechst 33258 (Fig. 2B), with visible
chromatin condensation compared to untreated control
cells.
The fluorescence-activated cell sorting (FACS) data to
assess apoptosis using Annexin VeFITC staining (Fig. 3A)
indicated a greater apoptotic potential of LC-5C than LC-
Figure 1 (A) Assessment of cell viability of HeLa cells before and after treatment with the drugs. (B) Assessment of cell viability
of HeLa cells before and after treatment with cisplatin, a potent anticancer drug. (C) Assessment of cell viability of peripheral
blood mononuclear cells (PBMCs) before and after treatment with the drugs. (D) Assessment of lactate dehydrogenase (LDH) ac-
tivity of HeLa cells before and after treatment with the drugs. * p < 0.001, y p < 0.01, z p < 0.05 versus placebo (alcohol) treated
series.
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the higher dose.3.4. Analysis of MMP
Compared to the control, the MMP of the drug-treated HeLa
cells showed a marked decrease in the intensity of thegreenish stain, indicating an effective depolarization of
MMP (Fig. 3B).3.5. Assessment of damage of DNA
DNA gel electrophoresis data showed that the LC-5C-
and LC-15C-treated groups showed a clear DNA smearing
Figure 2 (A) Apoptotic assay of HeLa cells by propidium iodide (PI) staining before and after treatment with the drugs.
(B) Apoptotic assay of HeLa cells by Hoechst 33342 staining before and after treatment with the drugs. * p < 0.001, y p < 0.01,
z p < 0.05 versus placebo (alcohol) treated series.
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(Fig. 4A).
3.6. Indirect ELISA study
A significant increase in the expressions of Bax, Apaf,
cytochrome C, and caspase 3 and a decrease in the
expression of Bcl2 were observed in the LC-5C- and LC-15C-
treated groups compared to untreated cells.4. Discussion
The hallmark feature of cancer cells that makes them
virtually immortal and unconquerable is their capability
for uncontrolled cell proliferation and ability to ignore
signals relating to apoptosis or cell death. Any external
agent or drug that can prevent, interfere with, or slow
down the process of proliferation or lead the cells to cell
death by apoptosis or necrosis can be considered as being
Figure 3 (A) Assessment of apoptosis by Annexin Vefluorescein isothiocyanate (FITC) and propidium iodide (PI) before and after
treatment with the drugs. (B) Qualitative analysis of mitochondrial membrane potential (MMP) in different sets of experimental
cells. * p < 0.001, y p < 0.01, z p < 0.05 versus placebo (alcohol) treated series.
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and devoid of any adverse side effects. The present
findings support the theory that both LC-5C and LC-15
induced a considerable percentage of cells to undergo
apoptosis, as revealed from the results of the different
study parameters. Therefore, the efficacy of bothpotencies of LC often used by homeopathic practitioners
in the treatment of certain disease conditions (symptoms)
including cancer, which would call for this remedy, can at
least be vindicated because the efficacy of these rem-
edies was demonstrated in the HeLa cancer cells. The
findings of the present study also support the claims made
Figure 4 (A) Estimation of DNA damage by gel electrophoresis of genomic DNA. (B) Quantitative expression (fold change) of
different proteins by indirect enzyme-linked immunosorbent assay (ELISA). * p < 0.001, y p < 0.01, z p < 0.05 versus placebo
(alcohol) treated series.
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areas [8,9].
The possible ways in which both LC-5C and LC-15C could
act were probably via the apoptotic signaling pathways.
This was evident from the fact that there were definite
changes in the parameters associated with apoptosis, such
as loss of percentage of viable cells, nuclear condensation,
laddering of genomic DNA, significant increase in LDH
release, expression of apoptotic genes, and so on, after
administration of LC-5C and LC-15C to HeLa cells, while
these favorable modulations were lacking in the placebo-
treated cells.
Mitochondria are known to be sensitive to changes in the
redox state of cells [17]. Maintenance of mitochondrial
membrane integrity is a dynamic process. Therefore, the
release of cytochrome C proteins into the cytosol might
actively contribute to the process of apoptosis [18].
Because apoptosis is highly dependent on the release of
certain mitochondrial enzymes, which is in turn associated
with mitochondrial membrane depolarization, we alsostudied this aspect of mitochondrial transmembrane po-
tential in view of its implications for apoptosis. Both drugs
showed positive modulations in this respect, thereby
implying that the drugs led the cancer cells to undergo
apoptosis via the release of cytochrome C into the cytosol.
There was clear evidence of upregulation and down-
regulation in the expression of pro-apoptotic (Bax) and
anti-apoptotic (Bcl2) genes, respectively, which provides an
insight into the fact that these drugs could initiate a
favorable change in the signal transduction mechanism,
which is involved in triggering and regulating the mecha-
nism of apoptosis in an orderly and sequential manner.
Activation of the caspase cascade is a well-known molec-
ular mechanism involved in the induction of apoptosis, and
caspase 3 is the key factor in the execution of apoptosis
[19]. There was an overexpression of caspase 3 in the HeLa
cells in the LC-5C- and LC-15C-treated groups at 24 hours,
whereas the placebo could not elicit such an effect. The
evidence that indicates the involvement of the phenome-
non of apoptosis as the main process of cancer cell
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percentage of cell damage, DNA damage, changes in
membrane potential, and activation of the caspase cascade
proteins. Although it is very difficult to explain why and
how this highly diluted drug could execute the relevant
modulations, there were certain clues suggesting that the
potentized homeopathic drugs were possibly triggering
action-specific genes that could have a regulatory influence
on the expression of other specific genes responsible for
bringing about the correct functioning of the recovery
process, which had gone astray in the diseased state.
The effect of dilution and succussion has been claimed
to be of enormous importance in the process of dynam-
ization of potentized homeopathic remedies. When the
drug was diluted to 12C or above, it crossed Avogadro’s
limit, meaning that the existence of even one molecule of
the original drug substance became highly improbabledthis
is the controversy that keeps many from believing in the
efficacy of such an ultrahigh dilution. Thus, the results of
well-designed experiments using the homeopathically
potentized diluted drugs and scientifically acceptable pa-
rameters of study are highly significant, even more so
because of the fact that the same dilutions of the succussed
ethanol (placebo) without the initial drug substance failed
to elicit similar responses at the molecular level [2,3,20].
Therefore, the results of the present investigation
actually vindicated the hypothesis long advocated by
Khuda-Bukhsh and his coworkers [4,5,20,21] and collabo-
rators [22] that one major way by which a potentized ho-
meopathic drug would act is by regulating the expression of
relevant genes, presumably by epigenetic modification.
However, further work will be necessary to clearly depict
the molecular pathway of action of ultrahigh diluted ho-
meopathic remedies.
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